Aminomethylbenzoic acid

When ATH:
B02AA03

Characteristic.

The white crystalline powder;, sparingly soluble in water.

Pharmacological action.
Antifibrinolytic, hemostatic.

Application.

Bleeding, due hyperfibrinolysis: Uterine, Pulmonary, kidney, perioperative; hypocoagulation phase in DIC, liver cirrhosis, gastric ulcer and duodenal ulcer, hemorrhagic syndrome, thrombocytopenic origin.

Contraindications.

Trombofilicescie state, accompanied by the development of thrombosis and thromboembolism, hypercoagulable phase DIC, severe coronary artery disease, or brain, chronic renal failure, pregnancy.

Pregnancy and breast-feeding.

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Side effects.

Dizziness, hypertension or hypotension (including orthostatic), nausea, vomiting, diarrhea, catarrhal phenomena from the upper respiratory tract.

Dosing and Administration.

Inside, 100–200 мг 3–4 раза в сутки. In the systemic bleeding, ДВС-синдроме — I / 50–100 мг или / m 100 mg. In the future, the dose is adjusted individually.

Precautions.

Make sure to record coagulation. It is necessary to ensure adequate fluid intake and monitor the adequacy of diuresis.